 | • レポートコード：MRC2-11QY04898 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は外傷性脳損傷治療のグローバル市場について調査・分析したレポートです。種類別（手術、薬）市場規模、用途別（病院、神経内科医センター、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別外傷性脳損傷治療の競争状況、市場シェア ・世界の外傷性脳損傷治療市場：種類別市場規模 2015年-2020年（手術、薬） ・世界の外傷性脳損傷治療市場：種類別市場規模予測 2021年-2026年（手術、薬） ・世界の外傷性脳損傷治療市場：用途別市場規模 2015年-2020年（病院、神経内科医センター、薬局） ・世界の外傷性脳損傷治療市場：用途別市場規模予測 2021年-2026年（病院、神経内科医センター、薬局） ・北米の外傷性脳損傷治療市場分析：米国、カナダ ・ヨーロッパの外傷性脳損傷治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの外傷性脳損傷治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の外傷性脳損傷治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの外傷性脳損傷治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Neuren Pharmaceuticals、TEVA Pharmaceutical Industries、Grace Laboratories、NeuroScience Pharmaceuticals、Tenax Therapeutics、Ischemix、Vasopharm、Amarantus BioScience、Silver Creek Pharmaceuticals、Stemedica Cell Technologies、Banayan Biomarkers ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Traumatic brain injury usually results from a violent blow or jolt to the head or body.
Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market
The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2178.1 million by 2026, from US$ 2112.1 million in 2020, at a CAGR of 2.9%% during 2021-2026.
Global Traumatic Brain Injuries Treatment Scope and Market Size
Traumatic Brain Injuries Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Traumatic Brain Injuries Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Neuren Pharmaceuticals
TEVA Pharmaceutical Industries
Grace Laboratories
NeuroScience Pharmaceuticals
Tenax Therapeutics
Ischemix
Vasopharm
Amarantus BioScience
Silver Creek Pharmaceuticals
Stemedica Cell Technologies
Banayan Biomarkers
Market segment by Type, the product can be split into
Surgery
Drugs
Market segment by Application, split into
Hospitals
Neurologist Centers
Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Traumatic Brain Injuries Treatment Revenue
1.4 Market by Type
1.4.1 Global Traumatic Brain Injuries Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Drugs
1.5 Market by Application
1.5.1 Global Traumatic Brain Injuries Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Neurologist Centers
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Traumatic Brain Injuries Treatment Market Perspective (2015-2026)
2.2 Global Traumatic Brain Injuries Treatment Growth Trends by Regions
2.2.1 Traumatic Brain Injuries Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Traumatic Brain Injuries Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Traumatic Brain Injuries Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Traumatic Brain Injuries Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Traumatic Brain Injuries Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Traumatic Brain Injuries Treatment Players by Market Size
3.1.1 Global Top Traumatic Brain Injuries Treatment Players by Revenue (2015-2020)
3.1.2 Global Traumatic Brain Injuries Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Traumatic Brain Injuries Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Traumatic Brain Injuries Treatment Market Concentration Ratio
3.2.1 Global Traumatic Brain Injuries Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Traumatic Brain Injuries Treatment Revenue in 2019
3.3 Traumatic Brain Injuries Treatment Key Players Head office and Area Served
3.4 Key Players Traumatic Brain Injuries Treatment Product Solution and Service
3.5 Date of Enter into Traumatic Brain Injuries Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Traumatic Brain Injuries Treatment Historic Market Size by Type (2015-2020)
4.2 Global Traumatic Brain Injuries Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
5.2 Global Traumatic Brain Injuries Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Traumatic Brain Injuries Treatment Market Size (2015-2020)
6.2 Traumatic Brain Injuries Treatment Key Players in North America (2019-2020)
6.3 North America Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
6.4 North America Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Traumatic Brain Injuries Treatment Market Size (2015-2020)
7.2 Traumatic Brain Injuries Treatment Key Players in Europe (2019-2020)
7.3 Europe Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
7.4 Europe Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
8 China
8.1 China Traumatic Brain Injuries Treatment Market Size (2015-2020)
8.2 Traumatic Brain Injuries Treatment Key Players in China (2019-2020)
8.3 China Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
8.4 China Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Traumatic Brain Injuries Treatment Market Size (2015-2020)
9.2 Traumatic Brain Injuries Treatment Key Players in Japan (2019-2020)
9.3 Japan Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
9.4 Japan Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Traumatic Brain Injuries Treatment Market Size (2015-2020)
10.2 Traumatic Brain Injuries Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
11 India
11.1 India Traumatic Brain Injuries Treatment Market Size (2015-2020)
11.2 Traumatic Brain Injuries Treatment Key Players in India (2019-2020)
11.3 India Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
11.4 India Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Traumatic Brain Injuries Treatment Market Size (2015-2020)
12.2 Traumatic Brain Injuries Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Traumatic Brain Injuries Treatment Market Size by Type (2015-2020)
12.4 Central & South America Traumatic Brain Injuries Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Neuren Pharmaceuticals
13.1.1 Neuren Pharmaceuticals Company Details
13.1.2 Neuren Pharmaceuticals Business Overview
13.1.3 Neuren Pharmaceuticals Traumatic Brain Injuries Treatment Introduction
13.1.4 Neuren Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020))
13.1.5 Neuren Pharmaceuticals Recent Development
13.2 TEVA Pharmaceutical Industries
13.2.1 TEVA Pharmaceutical Industries Company Details
13.2.2 TEVA Pharmaceutical Industries Business Overview
13.2.3 TEVA Pharmaceutical Industries Traumatic Brain Injuries Treatment Introduction
13.2.4 TEVA Pharmaceutical Industries Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.2.5 TEVA Pharmaceutical Industries Recent Development
13.3 Grace Laboratories
13.3.1 Grace Laboratories Company Details
13.3.2 Grace Laboratories Business Overview
13.3.3 Grace Laboratories Traumatic Brain Injuries Treatment Introduction
13.3.4 Grace Laboratories Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.3.5 Grace Laboratories Recent Development
13.4 NeuroScience Pharmaceuticals
13.4.1 NeuroScience Pharmaceuticals Company Details
13.4.2 NeuroScience Pharmaceuticals Business Overview
13.4.3 NeuroScience Pharmaceuticals Traumatic Brain Injuries Treatment Introduction
13.4.4 NeuroScience Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.4.5 NeuroScience Pharmaceuticals Recent Development
13.5 Tenax Therapeutics
13.5.1 Tenax Therapeutics Company Details
13.5.2 Tenax Therapeutics Business Overview
13.5.3 Tenax Therapeutics Traumatic Brain Injuries Treatment Introduction
13.5.4 Tenax Therapeutics Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.5.5 Tenax Therapeutics Recent Development
13.6 Ischemix
13.6.1 Ischemix Company Details
13.6.2 Ischemix Business Overview
13.6.3 Ischemix Traumatic Brain Injuries Treatment Introduction
13.6.4 Ischemix Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.6.5 Ischemix Recent Development
13.7 Vasopharm
13.7.1 Vasopharm Company Details
13.7.2 Vasopharm Business Overview
13.7.3 Vasopharm Traumatic Brain Injuries Treatment Introduction
13.7.4 Vasopharm Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.7.5 Vasopharm Recent Development
13.8 Amarantus BioScience
13.8.1 Amarantus BioScience Company Details
13.8.2 Amarantus BioScience Business Overview
13.8.3 Amarantus BioScience Traumatic Brain Injuries Treatment Introduction
13.8.4 Amarantus BioScience Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.8.5 Amarantus BioScience Recent Development
13.9 Silver Creek Pharmaceuticals
13.9.1 Silver Creek Pharmaceuticals Company Details
13.9.2 Silver Creek Pharmaceuticals Business Overview
13.9.3 Silver Creek Pharmaceuticals Traumatic Brain Injuries Treatment Introduction
13.9.4 Silver Creek Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.9.5 Silver Creek Pharmaceuticals Recent Development
13.10 Stemedica Cell Technologies
13.10.1 Stemedica Cell Technologies Company Details
13.10.2 Stemedica Cell Technologies Business Overview
13.10.3 Stemedica Cell Technologies Traumatic Brain Injuries Treatment Introduction
13.10.4 Stemedica Cell Technologies Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
13.10.5 Stemedica Cell Technologies Recent Development
13.11 Banayan Biomarkers
10.11.1 Banayan Biomarkers Company Details
10.11.2 Banayan Biomarkers Business Overview
10.11.3 Banayan Biomarkers Traumatic Brain Injuries Treatment Introduction
10.11.4 Banayan Biomarkers Revenue in Traumatic Brain Injuries Treatment Business (2015-2020)
10.11.5 Banayan Biomarkers Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Traumatic Brain Injuries Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Traumatic Brain Injuries Treatment Revenue
Table 3. Ranking of Global Top Traumatic Brain Injuries Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Traumatic Brain Injuries Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Drugs
Table 7. Global Traumatic Brain Injuries Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Traumatic Brain Injuries Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Traumatic Brain Injuries Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Traumatic Brain Injuries Treatment Market Share by Regions (2015-2020)
Table 11. Global Traumatic Brain Injuries Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Traumatic Brain Injuries Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Traumatic Brain Injuries Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Traumatic Brain Injuries Treatment Players
Table 18. Global Traumatic Brain Injuries Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Traumatic Brain Injuries Treatment Market Share by Players (2015-2020)
Table 20. Global Top Traumatic Brain Injuries Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traumatic Brain Injuries Treatment as of 2019)
Table 21. Global Traumatic Brain Injuries Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Traumatic Brain Injuries Treatment Product Solution and Service
Table 24. Date of Enter into Traumatic Brain Injuries Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Traumatic Brain Injuries Treatment Market Size Share by Type (2015-2020)
Table 28. Global Traumatic Brain Injuries Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Traumatic Brain Injuries Treatment Market Size Share by Application (2015-2020)
Table 30. Global Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Traumatic Brain Injuries Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 34. North America Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 36. North America Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 40. Europe Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 42. Europe Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 46. China Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 48. China Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 52. Japan Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 54. Japan Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 58. Southeast Asia Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 64. India Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 66. India Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Traumatic Brain Injuries Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Traumatic Brain Injuries Treatment Market Share (2019-2020)
Table 70. Central & South America Traumatic Brain Injuries Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Traumatic Brain Injuries Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Traumatic Brain Injuries Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Traumatic Brain Injuries Treatment Market Share by Application (2015-2020)
Table 74. Neuren Pharmaceuticals Company Details
Table 75. Neuren Pharmaceuticals Business Overview
Table 76. Neuren Pharmaceuticals Product
Table 77. Neuren Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 78. Neuren Pharmaceuticals Recent Development
Table 79. TEVA Pharmaceutical Industries Company Details
Table 80. TEVA Pharmaceutical Industries Business Overview
Table 81. TEVA Pharmaceutical Industries Product
Table 82. TEVA Pharmaceutical Industries Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 83. TEVA Pharmaceutical Industries Recent Development
Table 84. Grace Laboratories Company Details
Table 85. Grace Laboratories Business Overview
Table 86. Grace Laboratories Product
Table 87. Grace Laboratories Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 88. Grace Laboratories Recent Development
Table 89. NeuroScience Pharmaceuticals Company Details
Table 90. NeuroScience Pharmaceuticals Business Overview
Table 91. NeuroScience Pharmaceuticals Product
Table 92. NeuroScience Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 93. NeuroScience Pharmaceuticals Recent Development
Table 94. Tenax Therapeutics Company Details
Table 95. Tenax Therapeutics Business Overview
Table 96. Tenax Therapeutics Product
Table 97. Tenax Therapeutics Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 98. Tenax Therapeutics Recent Development
Table 99. Ischemix Company Details
Table 100. Ischemix Business Overview
Table 101. Ischemix Product
Table 102. Ischemix Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 103. Ischemix Recent Development
Table 104. Vasopharm Company Details
Table 105. Vasopharm Business Overview
Table 106. Vasopharm Product
Table 107. Vasopharm Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 108. Vasopharm Recent Development
Table 109. Amarantus BioScience Business Overview
Table 110. Amarantus BioScience Product
Table 111. Amarantus BioScience Company Details
Table 112. Amarantus BioScience Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 113. Amarantus BioScience Recent Development
Table 114. Silver Creek Pharmaceuticals Company Details
Table 115. Silver Creek Pharmaceuticals Business Overview
Table 116. Silver Creek Pharmaceuticals Product
Table 117. Silver Creek Pharmaceuticals Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 118. Silver Creek Pharmaceuticals Recent Development
Table 119. Stemedica Cell Technologies Company Details
Table 120. Stemedica Cell Technologies Business Overview
Table 121. Stemedica Cell Technologies Product
Table 122. Stemedica Cell Technologies Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 123. Stemedica Cell Technologies Recent Development
Table 124. Banayan Biomarkers Company Details
Table 125. Banayan Biomarkers Business Overview
Table 126. Banayan Biomarkers Product
Table 127. Banayan Biomarkers Revenue in Traumatic Brain Injuries Treatment Business (2015-2020) (Million US$)
Table 128. Banayan Biomarkers Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Traumatic Brain Injuries Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Drugs Features
Figure 4. Global Traumatic Brain Injuries Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Neurologist Centers Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Traumatic Brain Injuries Treatment Report Years Considered
Figure 9. Global Traumatic Brain Injuries Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Traumatic Brain Injuries Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Traumatic Brain Injuries Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Traumatic Brain Injuries Treatment Market Share by Players in 2019
Figure 14. Global Top Traumatic Brain Injuries Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traumatic Brain Injuries Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Traumatic Brain Injuries Treatment Revenue in 2019
Figure 16. North America Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Traumatic Brain Injuries Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
脳腫瘍治療の世界市場（～2026年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …- 心的外傷後ストレス障害（PTSD）治療薬の世界市場（～2026年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…
- 慢性外傷性脳症（CTE）の世界市場（～2026年） Chronic traumatic encephalopathy (CTE) is a kind of degenerative brain disease that is found in athletes, military veterans, and others with a history of repetitive brain trauma. Market Analysis and Insights: Global Chronic Traumatic Encephalopathy (CTE) Market The global Chronic Traumatic Encephalo…
- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- 脳疾患の世界市場（～2026年） Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of…